Home › Core › ISCC-IDs › 28CCB6UnkjbAT

View ISCC-ID

Core Data

28CCB6UnkjbAT
ISCC-ID - digital asset identifier
CCt3t8HrtCsjL-CT261Yzg6dz4T-CDmmvqni3AK5R-CR6VXFAZnh2pW
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

new treatment options in the management of fibromyalgia role of pregabalin

Ledger Reference

coblo
Source Ledger/Blockchain
12403563
N-th ISCC Decleration on source ledger
35eedf004fb5659a940f641ec769973e653452e3b318cb70e985f7f614bc9b42
Hash of block that includes the ISCC-DECLARATION
a9f7733ddf0e5194311724ca525093729ecca0c420fdf67649d0cf5e5c503813
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "New treatment options in the management of fibromyalgia: role of pregabalin", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Grazyna Zareba", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.dovepress.com/getfile.php?fileID=4281", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/8aa2/a67657eb49dc85d2112f488e8565d215dec8.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Informa UK Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.2147/ndt.s3257", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCt3t8HrtCsjL-CT261Yzg6dz4T-CDmmvqni3AK5R-CR6VXFAZnh2pW", "propertyID": "ISCC"}], "datePublished": "2008-09-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close